Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,563,196
-
Share change
-
-241,115
-
Total reported value
-
$143,564,877
-
Put/Call ratio
-
35%
-
Price per share
-
$56.01
-
Number of holders
-
76
-
Value change
-
-$13,399,464
-
Number of buys
-
40
-
Number of sells
-
27
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2025
As of 31 Dec 2025,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,563,196 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, ENVESTNET ASSET MANAGEMENT INC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, FIRST CITIZENS BANK & TRUST CO, Envestnet Portfolio Solutions, Inc., CITIGROUP INC, MORGAN STANLEY, BNP PARIBAS FINANCIAL MARKETS, and Cetera Investment Advisers.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.